Vivo Capital’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,817
| Closed | -$980K | – | 62 |
|
|
2020
Q1 | $980K | Buy |
+6,817
| New | +$980K | 0.09% | 52 |
|
|
2019
Q3 | – | Sell |
-16,157
| Closed | -$9.82M | – | 45 |
|
|
2019
Q2 | $9.82M | Sell |
16,157
-1,458
| -8% | -$886K | 0.92% | 28 |
|
|
2019
Q1 | $10.7M | Sell |
17,615
-8,862
| -33% | -$5.41M | 1.07% | 24 |
|
|
2018
Q4 | $9.66M | Hold |
26,477
| – | – | 1.23% | 23 |
|
|
2018
Q3 | $17.9M | Buy |
26,477
+10,180
| +62% | +$6.87M | 1.8% | 19 |
|
|
2018
Q2 | $14.2M | Hold |
16,297
| – | – | 1.83% | 16 |
|
|
2018
Q1 | $20.5M | Hold |
16,297
| – | – | 2.9% | 9 |
|
|
2017
Q4 | $24.4M | Hold |
16,297
| – | – | 5.22% | 7 |
|
|
2017
Q3 | $33.4M | Buy |
16,297
+211
| +1% | +$432K | 6.74% | 4 |
|
|
2017
Q2 | $42.1M | Hold |
16,086
| – | – | 10.61% | 4 |
|
|
2017
Q1 | $48.3M | Hold |
16,086
| – | – | 14.2% | 3 |
|
|
2016
Q4 | $24M | Buy |
16,086
+3,479
| +28% | +$5.18M | 7.9% | 4 |
|
|
2016
Q3 | $22.2M | Hold |
12,607
| – | – | 6.92% | 5 |
|
|
2016
Q2 | $23.6M | Hold |
12,607
| – | – | 6.46% | 4 |
|
|
2016
Q1 | $28.2M | Buy |
+12,607
| New | +$28.2M | 7.08% | 4 |
|